Follow the AGIOS PHARMACEUTICALS INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 10 February 2016 (Levée d'options). Among the most active insiders: Biller Scott. All data is free.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AGIOS PHARMACEUTICALS INC Buy (bullish), based on 8 analysts. Average price target: US$45.38.
Fundamental score
Ranked 22,935 of 28,833 companies
31.0
score / 100
Value
10
Quality
52
FCF yld-22%
Earn yld-23%
EV/EBITDA·
ROE-34%
Gross mgn88%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AGIOS PHARMACEUTICALS INC is a biopharmaceutical company focused on developing treatments for rare diseases and cancer. The company is dedicated to the discovery and commercialization of innovative medicines.